D
ysbiosis of gut microbiota disrupts intestinal homeostasis and causes inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis (UC). Hence, restoration of gut microbiota symbiosis is key to the prevention and treatment of IBD [1] [2] [3] . One promising agent that has been shown to shape the gut microbiota community is intestinal IgA [4] [5] [6] [7] . Intestinal IgA is thought to comprise two types: (1) high-affinity IgA, which is produced by a somatic hypermutation (SHM) process in germinal centre (GC) B cells and reacts specifically to pathogens and their toxins in a Fab-dependent manner; (2) poly-reactive IgA, which is produced by a GC-independent process and recognizes a variety of commensal bacteria, probably in a Fab-independent manner 4, 5, 8 . IgA coating of commensal bacteria was originally discovered as early as 1968 (ref. 9) . A recent study refocused on IgA coating and suggested that intestinal IgA selectively coat diseaseassociated commensal bacterial taxa 7, 10 , although how IgA can specifically select colitogenic bacteria has remained unclear.
Our previous studies revealed that, even in the absence of pathogens, mice that lack whole IgA (activation-induced cytidine deaminase (AID) deficient mice) and mice that lack only high-affinity IgA due to an SHM defect (AID G23S -glycine to serine at the 23rd amino acid-mutant mice) developed immune hyperactivation and dysbiosis-associated lymphoproliferative disease 11, 12 . These data demonstrate that only high-affinity IgA, not low-affinity IgA, plays a crucial role in the control of commensal gut microbiota as well as of pathogens. Because gut microbiota contain a huge number of varied species, we thought that only polyreactive IgA could shape and maintain the microbial community in a steady state. We thus hypothesized that high-affinity polyreactive IgA could be a useful gut commensal modulator to restore symbiosis.
In this study, we isolated monoclonal IgA antibodies and identified their target bacterial epitopes. Interestingly, more than 90% of monoclonal IgAs derived from the small intestine of mice recognized an epitope that represented four amino acids (EEHI) expressed in a bacterial enzyme, serine hydroxymethyltransferase (SHMT). Among those IgAs, we selected a high-affinity polyreactive W27 IgA as the best candidate for an efficient gut microbiota modulator and showed that W27 oral treatment modulated gut microbiota composition and had a therapeutic effect on both lymphoproliferative disease and colitis models in mice. unrelated sequence of a variable region gene in the immunoglobulin heavy chain (V H ; Supplementary Table 1) . We tested their binding ability against 14 different cultivable commensal bacterial strains with an enzyme-linked immunosorbent assay (ELISA). All 16 monoclonal IgAs recognized at least three different bacterial strains at an antibody concentration of 1.4 µg ml -1 (Fig. 1a) . We selected four clones (W2, W27, W34 and W43) producing antibodies in relatively high amounts and tested their relative binding ability against 14 different strains with a dose-dependent ELISA assay. Of the four, W27 had the most potent reactivity against 12 of the 14 bacterial strains (Fig. 1b and Supplementary   Fig. 1 ). Interestingly, W27 bound to each bacterial strain with variable binding strength. The relative reactivities of W27 to Escherichia coli, Staphylococcus lentus and Pseudomonas fulva were about 100 times higher than those of W2, while the reactivities of W27 to Bifidobacterium bifidum and Blautia coccoides (previously classified as Clostridium (C.) coccoides, one of the beneficial bacteria that induces FoxP3 + regulatory T cells) 13 were only ten times higher than those of W2. W27 had very weak reactivity, if any, to Lactobacillus casei (a species of genus Lactobacillus generally considered to be probiotic) (Fig. 1b) . We assumed that W27 is the best candidate for a commensal microbiota regulator, because it selectively binds to a series of commensal bacteria (including a Data were obtained from five technical replicated sorting and sequencing procedures. Source data are provided online (see 'Accession codes').
potentially colitogenic one) rather than to beneficial ones such as B. bifidum, B. coccoides and L. casei.
High-throughput analysis of W27-binding bacteria. We also analysed the selective binding ability of W27 by IgA-seq of sorted W27-binding and W27-non-binding gut bacteria from the gut contents of IgA-null AID −/− mice (Fig. 1c) . Family-level analysis identified Porphyromonadaceae, Prevotellaceae and Lactobacillaceae as W27-binding bacteria and Lachnospiraceae and Ruminococcaceae as W27-non-binding bacteria (Fig. 1c) . A previous study 7 has demonstrated that a high IgA coating identifies colitogenic bacteria in a mouse colitis model as well as in IBD patients. In that study 7 and in another report 14 , Lactobacillaceae and Prevotellaceae appeared as potentially colitogenic commensal bacteria, whereas Lachnospiraceae and Ruminococcaceae were recognized as beneficial bacteria, for example, as Tregs inducers 13, 15 . These findings suggested that W27 could adjust the gut microbiota to achieve symbiotic balance, through selective binding to colitogenic bacteria rather than beneficial bacteria.
Mouse intestinal IgAs recognize an E. coli enzyme SHMT. We also tried to identify the target molecule of IgA clones through western blot analysis with comparable amounts of cell lysate from seven different bacterial strains, including a commercially available E. coli strain (DH5α), a mouse cell line (NS-1) and a human cell line (293T). Four IgA monoclonal antibodies (W27, W2, W34 and W43) revealed visible target bands for DH5α, E. coli (a strain isolated from mouse faeces) and P. fulva. In contrast, none of the IgAs recognized any protein in S. lentus, L. casei, B. coccoides, B. bifidum, NS-1 and 293T cells, except for ambiguous bands for B. coccoides on the W27 blot ( Fig. 2a and Supplementary Fig. 6 ). This suggests that the specific target protein of the four IgAs is most probably a common molecule expressed by E. coli and P. fulva ( Fig. 2a and Supplementary  Fig. 6 ). We performed mass spectrometry analysis of a target protein from the DH5α cell lysate and found that the target molecule of W27 is the enzyme serine hydroxymethyltransferase (SHMT). Interestingly, the other independent IgA clones (W2, W34 and W43) also recognized Myc-tagged cloned E. coli SHMT as well as endogenous SHMT (Fig. 2b and Supplementary Fig. 6 ). SHMT is an important metabolic enzyme that catalyses the reversible methylation reaction of serine and tetrahydrofolate (THF) to glycine and 5,10-methylene THF. In previous studies, SHMT was detected in the periplasm fraction of E. coli [16] [17] [18] , suggesting that IgA could recognize SHMT on the surface of E. coli.
Epitope of SHMT recognized by W27. According to our database search, the gene encoding SHMT, glyA, is not found in the genome of B. bifidum, but a wide range of bacteria have the gene. To check whether W27 also recognizes the SHMT proteins in other bacterial species, we cloned the full-length glyA gene encoding SHMT from P. fulva, S. lentus, L. casei and B. coccoides, as well as the human SHMT. We then overexpressed their Myc-tagged SHMT proteins in 293T cells. As shown in Fig. 2c and Supplementary Fig. 6 , W27 recognizes the SHMT of P. fulva as well as of E. coli, but not other bacterial or human SHMT proteins. This suggests that W27 can distinguish differences in the amino acid (AA) sequences of each distinct bacterial SHMT.
A further epitope mapping study of E. coli SHMT revealed that W27 specifically recognized the peptide SHMT-P1 (AA25-AA45 of E. coli SHMT; Fig. 2d and Supplementary Fig. 6 ). Through alignment of the amino acid sequences of SHMT from different species, we found the highly conserved motif (RQ-XXXX-ELIASEN) in the N-terminal region of SHMT and further identified four amino acids (EEHI) in the middle of the conserved motif (RQ-XXXX-ELIASEN) as a critical determinant of W27 binding, which is shared by E. coli and P. fulva (Fig. 2d and Supplementary Fig. 6 ). To ensure that the EEHI residues were the core epitope sequence, we generated and overexpressed mutant E. coli SHMT protein (replacing EEHI with EHNI) and mutant L. casei SHMT, replaced reciprocally in 293T cells. Western blot analysis clearly showed that W27 specifically recognized EEHI but not EHNI in SHMT (Fig. 2e and Supplementary Fig. 6 ), indicating that EEHI is a critical target sequence for W27.
With a dose-dependent binding assay, we further confirmed that W27 had the most potent reactivity to SHMT-P1 of the four IgA clones (Fig. 2f ) . Interestingly, the other IgA antibodies (W2, W34 and W43) also recognized the same SHMT-P1, but myeloma-derived mouse IgA (mIgA) did not recognize it at all (Fig. 2f ) , suggesting that SHMT-P1 is a common bacterial target for intestinal IgA. Indeed, 42 out of 44 monoclonal IgAs, including the 16 clones shown in Fig. 1a and additional monoclonal IgAs derived from other mice, could bind to the peptide containing the EEHI sequence ( Supplementary Fig. 2 ). According to our database search, E. coli shares the EEHI amino acid sequence not only with P. fulva (Fig. 2d) but also with a range of pathogenic bacteria, including Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Salmonella paratyphi A, Salmonella typhimurium and Shigella flexneri (Supplementary Table 2 ). It is reasonable to conclude that most intestinal IgAs recognize the EEHI sequence as an element of mucosal defence.
Bacterial growth suppression by W27 IgA. Our hypothesis agrees with the idea that IgA-binding of colitogenic bacteria may improve dysbiosis 5, 7 . However, its mechanism is unknown. One possibility is that a high-affinity IgA such as W27 may inhibit bacterial cell growth by binding, but does not affect the cell growth of nonbinding beneficial bacteria, leading to the establishment of hostmicrobiota symbiosis. To prove this hypothesis, we tested whether W27 binding could have any effect on bacterial cell growth. For in vitro growth assay, we purified W27 by affinity chromatography against SHMT-P1 peptide. The purified fraction of W27 mainly consisted of oligomers ( Supplementary Fig. 3 ). Co-culture of affinity-purified W27 and DH5α cells significantly inhibited their cell growth in a dose-dependent manner (Fig. 3a) , whereas nonbinding mIgA (derived from myeloma cells, Fig. 3b ) did not affect it at all (Fig. 3a) . By contrast, the cell growth of L. casei that were not bound by W27 (Figs 1b and 3b) was not altered by W27. These results suggest that binding of bacteria by W27 can suppress their cell growth.
It has been demonstrated that IgAs bind to bacteria in a Fabindependent, non-specific manner [4] [5] [6] 8, 9 . To investigate this we took advantage of SHMT-deficient E. coli (JW2535) (Fig. 3e and Supplementary Fig. 6 ) 19 . Because SHMT is one of the key enzymes for one-carbon metabolism, JW2535 cells exhibits growth retardation (Fig. 3c) , as reported previously 20 . W27 suppressed only wild-type (ME9062) cell growth significantly, and did not affect SHMTdeficient cell (JW2535) growth (Fig. 3c) , although W27 bound to both strains equally (Fig. 3d,f) . Our results indicate that W27 has an inhibitory effect on E. coli cell growth via SHMT recognition.
Oral treatment of W27 improves lymphoproliferative disease and associated pathological crypt damage in AID G23S mice. We reasoned that the proposed role of W27 in modulating intestinal microbiota, leading to symbiosis, needed to be confirmed in an in vivo model lacking high-affinity IgA antibodies. Currently, AID G23S knock-in mice are the best candidate mice for this 12 . We examined whether oral supplementation of W27 could prevent lymphoproliferation in AID G23S mice. W27 (partially purified via ammonium sulfate precipitation, Supplementary Fig. 3 ) was given to AID G23S mice in their drinking water at a concentration of 25 µg ml
for four weeks. As a control treatment, low-affinity polyreactive IgA (W2, Figs 1b and 2f ) was given to AID G23S mice in the same manner. These IgA antibodies consisted of both monomer and oligomer forms and were stable in the drinking water for at least seven days ( Supplementary Fig. 3 ). They were delivered through the whole intestine and could be recovered from faeces ( Supplementary Fig. 4 ). Compared to untreated AID G23S mice suffering from GC B cell hyperplasia, GC B cell numbers in Peyer's patches (PPs) of W27-treated AID G23S mice were significantly decreased (P < 0.01) down to the level of those of wild-type mice (Fig. 4a) . On the other hand, W2 treatment did not affect it significantly (Fig. 4a) . Furthermore, 30 µg of W27 (affinity-purified) was given by gavage twice a week to IgA-null AID −/− mice suffering more prominent GC hyperplasia than AID G23S mice. Oral W27 treatment for four weeks significantly decreased GC B cell numbers in the PPs of AID −/− mice (Fig. 4b ). In addition, diffuse crypt atrophic damage found in eight (>30% of total colonic length) and two (5-30% of total colonic length) out of thirty AID G23S mice at 12-16 weeks of age was not observed in any of the thirteen W27-treated AID . SDS-PAGE gels were applied to either western blot with antibody (W27, W2, W34 and W43) or Coomassie brilliant blue (CBB) staining to confirm that comparable amounts of each protein were loaded. b, Four IgAs recognized a single molecule (SHMT) in DH5α. Overexpressed Myc-tagged E. coli SHMT in DH5α was detected, as well as endogenous SHMT. Note that the total DH5α lysate amounts loaded onto each gel were not identical. c, Myc-tagged cloned SHMT proteins derived from five bacteria and human were overexpressed in 293T cells to confirm binding by W27. d, Amino acid sequences of three synthesized peptides (SHMT-P1∼P3). Conserved and variant amino acid sequences are shown in black and red, respectively. Underlined red residues are the core epitope for W27. e, Myc-tagged mutant SHMT proteins (E. coli SHMT mut-EHNI and L. casei SHMT mut-EEHI ) were overexpressed in 293T cells. f, Relative affinity of each purified IgA against SHMT-P1-BSA. mIgA, myeloma-derived mouse IgA. Data are representative of two or three independent biological experiments. Entire gels and blots are provided in Supplementary Fig. 6a-e. mice (Fig. 4c,d ). We concluded that W27 oral supplementation could prevent lymphoproliferative disease and the associated crypt damage in AID G23S and AID −/− mice.
Oral W27 treatment changes gut microbiota composition. We questioned whether W27 IgA directly affects gut microbiota composition. Through bacterial 16S rRNA meta sequencing, we found that W27 oral administration to AID G23S mice induced a significant change in the relative abundance of 12 different bacterial families (Fig. 4e) . The relative abundance of Lachnospiraceae and Ruminococcaceae were significantly increased after W27 oral treatment (Fig. 4e) . These bacterial species are generally considered Figure 3 | W27 suppressed E. coli cell growth via SHMT-specific recognition. a, Between 300 and 500 cells of DH5α and L. casei were incubated with affinity-purified W27 or control mouse IgA (mIgA) at the designated concentration for 3 h at 37°C. The DH5α and L. casei cells were then incubated with growth medium at 37°C for an additional 7 and 45 h, respectively, until the numbers of cells were comparable. **P < 0.01, *P < 0.05. Analysis of variance (ANOVA) was performed, followed by Bonferroni-Holm post-hoc tests for multiple comparisons. b, IgA surface staining of E. coli and L. casei. c, E. coli cells (0.8 × 10 5 to 1.2 × 10 5 cells) were incubated with affinity-purified W27 or control mouse IgA (mIgA) at designated concentration for 3 h at 37°C. The samples were then incubated for an additional 3 h with growth medium at 37°C. **P < 0.001 versus without W27. Statistical analysis was performed by twosided Mann-Whitney test. ME9062, SHMT-proficient E. coli; JW2535, SHMT-deficient E. coli. Each dot represents the mean of three technical replicates (a,c).
In a and c, data were collected from three to nine independent biological experiments, and all data are expressed as medians ± range. to be beneficial Tregs inducers 13, 15 . On the other hand, Prevotellaceae and Lactobacillaceae, plausible colitogenic bacteria 7, 14 , decreased in relative abundance in response to W27 treatment (Fig. 4e) . In good agreement with our W27 IgA-seq data (Fig. 1c) , the numbers of bacteria bound strongly by W27, such as Lactobacillaceae and Prevotellaceae, decreased in faeces after W27 oral treatment, while numbers of bacteria bound weakly by W27, such as Lachnospiraceae and Ruminococcaceae, increased in faeces after W27 oral treatment (Figs 1c and 4e) . In addition, quantitative PCR analysis 21 revealed that W27 oral treatment significantly increased the absolute numbers of the B. coccoides group (corresponding to Lachnospiraceae in 16S rRNA analysis) and the Clostridium leptum group (corresponding to Ruminococcaceae in 16S rRNA analysis) ( Supplementary Fig. 5 , left half, and Supplementary Table 3), whereas W2 (low-affinity IgA) oral treatment did not change them, except for a slight decrease in Prevotella ( Supplementary Fig. 5, right half) . The significant shift in composition of the microbiota after W27 oral treatment was further confirmed at the individual mouse level (P < 0.05) (Fig. 4f) . Thus, as expected from its beneficial effect on lymphoproliferative disease, W27 oral treatment modulated gut microbiota composition towards symbiosis.
W27 oral treatment has a beneficial effect on experimental colitis in mice by modulating gut microbiota. We next addressed the question of whether W27 oral treatment could prevent colitis induced by dextran sodium sulfate (DSS). As shown previously, when dysbiosis was induced in wild-type mice by co-housing them with colitogenic mice or by exposing them to colitogenic bacteria, the mice showed more severe body weight loss than untreated wild-type mice in DSS-induced colitis experiments 7 . As W27 targets dysbiosis, but not inflammation itself, we assume that W27 supplementation may ameliorate the severity of DSS-induced colitis in mice suffering from dysbiosis. To induce dysbiosis in wild-type mice, we repeatedly administered DSS in their drinking water, with intervals with supplementation of W27 in the water or water only (Fig. 5a ). W27 oral treatment significantly reduced the bodyweight loss and the increase in disease activity index 22 ( Fig. 5a,b) . A previous study 7 has shown that the IgA-binding proportion of intestinal bacteria is significantly increased in IBD patients and in a mouse model of colitis. At the end of the experiment, in W27-treated mice, the IgA-binding proportion of faecal bacteria was significantly decreased compared to that in control mice (Fig. 5c) , suggesting an improvement in gut microbial composition by W27. Indeed 16S rRNA analysis revealed a significant difference in the microbial composition between W27-treated and untreated mice (Fig. 5d ). Finally, we tested whether W27 could prevent another colitis model induced by adoptive transfer of CD4 + CD45RB high T cells in Rag1
−/− mice in another independent animal facility. W27 treatment clearly ameliorated the wasting disease (Fig. 5e ) associated with chronic colitis 23 ( Fig. 5f,g ). We confirmed that the microbiota compositions in W27-treated and untreated mice were significantly different three weeks after T cell transfer (Fig. 5h) . Because the microbial conditions in each animal facility were not identical, additional studies are required to define the dysbiosis condition that W27 can target. However, our data suggest that W27 oral treatment can have a beneficial effect on colitis originating from different mechanisms, but is associated with dysbiosis.
Discussion
In this study we have isolated a monoclonal IgA antibody, W27, that has a strong binding ability against a variety of bacteria and suppresses the cell growth of E. coli via an epitope-specific binding, but neither binds to nor suppresses L. casei in vitro. In gut lumen, orally given W27 modulates commensal microbiota composition towards symbiotic balance, resulting in beneficial effects on several dysbiosis-associated disease models in mice. Recent studies have shown that secreted intestinal IgA can recognize and bind to a subset of commensal bacteria that preferentially affect IBD susceptibility in mice and human patients 7, 10 . This subset of bacteria may vary depending on the environment, such as the mouse facilities, and it is difficult to identify a disease-causing bacterium in each human patient. A new approach based on targeted microbial modulation such as W27 oral treatment may overcome this difficulty and contribute to the cure of IBD patients, because W27 selectively binds preferably to multiple colitogenic bacteria through epitope-specific recognition. However, several questions of critical importance have never been solved.
We have demonstrated that simple IgA coating of the bacteria did not always inhibit bacterial growth. Our findings agree with an early paper published in 1968 demonstrating that certain bacteria continue to grow despite being IgA-coated 9 . Thereafter, nonspecific binding was thought to occur via carbohydrates on the bacterial cell surface and IgA molecule 8 . Recently, Mathias and colleagues have demonstrated the significant difference between IgA binding on the cell surface in E. coli strains and in Lactobacillus 24 . Their results show that the interaction of three tested Gram-negative bacteria (E. coli strains) with deglycosylated or native IgA proteins results in similar high-level binding, while the interaction of Gram-positive bacteria such as Lactobacillus and Bifidobacterium was lost by deglycosylated IgA, suggesting a selective role of carbohydrates in the binding of Gram-positive bacteria. In good agreement with these findings, we observed equal levels of surface binding of W27 to E. coli strains ME9062 and JW2535 (Fig. 3d,f ) , indicating epitope (SHMT)-independent binding on E. coli by W27 IgA. A future study is required to determine the unknown molecular patterns involved in IgA binding to E. coli.
We also addressed the question of what type of molecule W27 IgA recognizes to control the diverse commensal bacteria. We identified the epitope of W27 at the amino acid residue level. W27 recognizes the EEHI sequence of SHMT in highly specific manner (Fig. 2d,e) . To understand the physiological importance of the EEHI motif in SHMT, we searched the bacterial species that share EEHI in SHMT among 2,739 strains whose genome sequences were available. They mostly belong to Gammaproteobacteria and Betaproteobacteria, including many pathogens (Supplementary  Table 2 ). Because we generated IgA-producing hybridomas from unimmunized mice kept under SPF conditions, the mice had never been exposed to the pathogens listed in Supplementary  Table 2 . The intestinal IgA that reacted with the EEHI sequence seemed to be preferentially selected in vivo ( Supplementary  Fig. 2 ). From our database search, we found that the bacterial species that do not have a glyA gene encoding SHMT included several beneficial probiotic bacteria such as B. bifidum BGN4 and Faecalibacterium prausnitzii L2-6 (and similar). Thus, for both mucosal defence and the maintenance of symbiosis, the EEHI sequence that we identified can be a key sequence for bacterial selection by IgA in mice. We believe it is worth identifying the corresponding target sequence in humans.
Methods
Animal experiments. Unless specifically mentioned, mice were kept and bred under SPF conditions at Nagahama Institute of Bioscience and Technology. The Animal Research Committees of Nagahama Institute of Bioscience and Technology, Yakult Central Institute and IMS-RCAI approved all animal experiments. Unless otherwise indicated, almost equal numbers of male and female BALB/c background mice were used for all mouse studies. All mice were between 8 and 18 weeks old, except for the mice used in Fig. 1c . No statistical methods were used to predetermine sample sizes. Animals were not randomized, and the data collected were not blinded. The investigators were not blinded to allocation during experiments and outcome assessment except for the experiments in Fig. 5f . Hybridoma generation. Small intestines were collected and opened longitudinally, washed with PBS to remove all luminal contents and shaken in PBS containing 5 mM EDTA for 20 min at 37°C. Epithelial cells were removed, and lamina propria layers were cut into small pieces and incubated with RPMI1640 containing 2% fetal bovine serum, 0.5 mg ml -1 collagenase and 0.5 mg ml -1 dispase for 1 h at 37°C with shaking. After the remaining tissues were removed, isolated lamina propria cells were washed with PBS and fused with NS-1 cells using polyethylene glycol. The cell fusion and subcloning method followed the manufacturer's protocol (ClonaCell-HY Hybridoma Cloning Kit, STEMCELL Technologies). IgA-secreting hybridomas were selected by standard sandwich ELISA with goat anti-mouse IgA (Southern Biotech) and alkaline phosphatase-conjugated goat anti-mouse IgA (Southern Biotech).
IgA preparation for ELISA and oral treatment of mice. The ascites from RAG2 −/− Jak3 −/− mice 25 injected intraperitoneally with IgA-producing hybridoma or culture supernatants of IgA-producing hybridoma were collected and filtered. An equal volume of saturated ammonium sulfate solution was added to precipitate the IgA antibodies. After incubation at 4°C for 24 h, samples were centrifuged for 20 min at 10,000g and 4°C. The pellet was reconstituted with 50% ammonium sulfate solution and centrifuged again. Finally, the pellet was reconstituted with PBS, followed by buffer change to PBS on a PD-10 column (GE Healthcare).
IgA affinity-purification for immunoblot analysis, bacterial growth inhibition assay and flow cytometry. Antibody solutions precipitated with ammonium sulfate solution, as above, were further purified by affinity chromatography on a HiTrap column (GE Healthcare) conjugated with SHMT-P1-BSA for W27 or HiTrap column conjugated with goat anti-mouse IgA antibody (Southern Biotech) for W2, W34 and W43. Standard ELISA was used to determine the concentration of each purified IgA antibody. For bacterial growth inhibition assay, purified mouse IgA purchased from Immunology Consultants Laboratory was applied onto a PD-10 column to eliminate sodium azide and incubated with DH5α cells.
ELISA for binding assay against bacteria. All bacteria were cultured at 37°C overnight in appropriate media, as shown in Supplementary Table 4 , under anaerobic conditions (80% N 2 , 10% H 2 , 10% CO 2 ) in an anaerobic chamber (Coy Laboratory Products) or in an aerobic chamber. The cells were centrifuged, washed with PBS and suspended in 0.05 M Na 2 CO 3 buffer to coat the plates (NUNC Maxisorp) at a concentration of ∼1 × 10 8 cells per well, except for B. coccoides and B. bifidum (∼1 × 10 7 cells per well). The relative binding ability of IgA was detected with alkaline phosphatase-conjugated goat anti-mouse IgA (Southern Biotech). ELISA plates were incubated at 4°C overnight, then optical density (OD) values were estimated.
ELISA for binding assay against synthesized peptides. Synthesized peptides (SHMT-P1∼P3) conjugated with BSA were obtained from Sigma and were suspended in 0.05 M Na 2 CO 3 buffer at 1 µg ml -1 to coat the plates. The relative binding abilities of purified monoclonal IgA antibodies were measured as described above. OD values were estimated after incubation at 25°C for 30 min.
Immunoblot analysis for bacteria and mammalian cells. All bacteria were cultured under appropriate conditions as described above. NS-1 and 293T cells were cultured in RPMI1640 and DMEM medium, respectively, supplemented with 10% fetal calf serum, 2-ME and gentamycin. The bacterial cells were centrifuged and suspended in PBS containing 1% NP-40 and a proteinase-inhibitor cocktail (Nacalai). For S. lentus, L. casei, B. coccoides and B. bifidum, lysozyme (0.2 mg ml -1 ; Wako) was added in PBS, then sonicated and incubated for 30 min on ice. Total lysates were denatured for SDS-PAGE. Mammalian cells were centrifuged, washed with PBS and suspended directly in SDS buffer for heat denaturation. After electrophoresis, all proteins were transferred onto a nitrocellulose filter. The filter was incubated with blocking buffer (LI-COR) followed by 2 µg ml -1 each of purified monoclonal IgA. To detect the bound IgA, goat anti-mouse IgA (Southern Biotech) and IR800-conjugated anti-goat IgG (LI-COR) were used. The signals were then visualized on an Odyssey scanner (LI-COR). To assess the amount of loaded bacterial protein, the duplicated SDS-PAGE gel was stained with Coomassie brilliant blue (Nacalai). For Myc-tagged protein detection, anti-Myc-tag antibody (MBL, clone PL14) and IRDye 800-conjugated anti-rabbit IgG (Rockland) were used.
Bacterial cell growth inhibition assay. DH5α and L. casei were cultured in brain heart infusion broth (Fluka Analytical) and Difco Lactobacilli MRS broth (BD) at 37°C overnight, respectively. They were then centrifuged, washed twice with PBS, and diluted to ∼300-500 cells per 25 µl in PBS supplemented with 1% (wt/vol) BSA and 20% normal rat serum and incubated for 3 h at 37°C with or without purified W27 IgA or mIgA (myeloma-derived mouse IgA purchased from Immunology Consultants Laboratory). After 3 h incubation, DH5α and L. casei were incubated for an additional 7 and 45 h at 37°C in each growth medium for growth suppression assay (in Fig. 3a) . For Fig. 3c, ME9062 and JW2535 cells were cultured in LB broth at 37°C overnight, and then centrifuged, washed twice with PBS and diluted to ∼0.8 to 1.2 × 10 5 cells per 25 µl in PBS supplemented with 1% (wt/vol) BSA and 20% normal rat serum. The cells were incubated with the designated IgA antibodies at 37°C for 3 h and further incubated at 37°C for 3 h with LB broth (final concentration, ×0.33).
The cells were then lysed in buffer A (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1 mM EDTA (pH 8.0), 0.5% SDS) on Bead Smash (TOMY) and incubated in the presence of proteinase K (0.2 mg ml -1 , Nacalai) overnight at 55°C. DNA was isolated by phenol/chloroform extraction and precipitated by ethanol. Finally DNA was dissolved in TE buffer. DNA was subjected to quantitative PCR with KAPA SYBR FAST qPCR Kit Optimized for LightCycler 480 (KAPABIOSYSTEMS) with DH5α-specific primers (F: 5′-ACCTTCGGGCCTCTTGCC-3′ and R: 5′-TTCCTCCCCGCTGAAAGTAC-3′) and L. casei-specific primers (F: 5′-TGGCGCAAGCTATCGCTTTT-3′ and R: 5′-CGCCGACAACAGTTACTCT-3′) to measure cell numbers. DNA samples purified from the corresponding numbers of DH5α and L. casei cells were used as qPCR standard to obtain the cell number of each sample.
Isolation of bacterial strains from mouse faeces. Fresh faeces from wild-type mice kept in the SPF area of Nagahama Institute were suspended in PBS on Bead Smash (TOMY). Diluted faeces with PBS were seeded onto blood-agar plates. The plates were incubated under aerobic or anaerobic conditions at 37°C for two or three days, and individual colonies on the plates were picked up for PCR to identify the 16S rRNA gene sequences. Primers for PCR were as follows: 27F (5′-GGAGRRTTTGATYHTGGYTCAG-3′) and 1492R (5′-GGGBTACCTTGTTACGA CTT-3′). The resulting sequences were compared with sequences in the ribosomal database project (RDP) database and genome database using BLAST to determine close species/strains. Identified colonies were cultured independently and stored for subsequent experiments. For IgA binding screening, we used 14 strains of bacteria, which included six isolated strains from mouse faeces and eight clones purchased from ATCC.
Mass spectrometry analysis. Immunoprecipitated proteins with W27 antibody from DH5α cell lysate were electrophoresed on two-dimensional SDS-PAGE gel. The W27-bound spot was separated and subjected to standard mass spectrometry. Briefly, the sample was loaded onto a nano-LC equipped with PicoFrit column (New Objective) directly coupled to a nanospray tip of an high performance liquid chromatograph ion-trap time-of-flight mass spectrometer system (Shimadzu).
Construction of SHMT expression vector. The full-length glyA gene encoding SHMT of DH5α was amplified with the following primers: SHMT-NotIF (5′-CCGCGGCCGCCCATGTTAAAGCGTGAAA-3′) and SHMT-NotIR (5′-AGAGCGGCCGCCTGCGTAAACCGGGTAAC-3′), where underlined sequences represent the recognition sites for NotI. PCR fragment was cloned into pcDNA3.1 (+) (Invitrogen) with 3X Myc-tag at its 3′-end. Other primers for cloning of different bacterial strains are shown in Supplementary Table 5 .
The primers used for mutagenesis were as follows: E. coli SHMT mutF (5′-CAGGAACACAACATCGAACTGATCGCC-3′), E. coli SHMT mutR (5′-GATGTGGTGGTTCTGACGTACTTTTTC-3′), L. casei SHMT mutF (5′-CGTCAGGAGGAGCATATCGAACTCATTGCC-3′) and L. casei SHMT mutR (5′-TTCGATATGCTCCTCCTGACGCTCTTCTTC-3′).
Bacterial flow cytometry and sorting of W27 binding and non-binding bacteria. The gut contents of small intestine, caecum and large intestine from four male AID −/− mice (21 weeks of age) were collected and suspended in 50 ml PBS. Immunostaining and sorting were performed according to a previous report 7 with minor modifications. Briefly, washed bacteria were suspended in 100 µl PBS containing 1% (wt/vol) BSA and 20% rat normal serum (Wako), incubated for 20 min on ice and then stained with 100 µl buffer containing 250 µg ml -1 of W27 for 30 min on ice. Samples were washed three times and then stained with PE-conjugated anti-mouse IgA (eBioscience, clone mA-6E1). IgA coating of bacteria was determined by flow cytometry (Fig. 3) , performed as described above. For bacterial sorting from gut contents, magnetic activated cell sorting (MACS) sorting was carried out on LS columns with anti-PE MACS beads (Miltenyi Biotec) according to the manufacturer's instructions. After MACS separation, the W27-binding and W27-non-binding fractions were further purified on a cell sorter (FACSAria, BD Biosciences).
16S rRNA gene sequencing and analysis for W27 binding and non-binding bacteria. Bacterial DNA was isolated and purified according to the literature 26 with minor modifications. In brief, bacterial samples were incubated with 15 mg ml -1 lysozyme (Wako) at 37°C for 1 h, followed by incubation with purified achromopeptidase (2,000 units per ml; Wako) at 37°C for 30 min. The samples were then incubated with 1% sodium dodecyl sulfate and 1 mg ml -1 proteinase K (Merck) at 55°C for 1 h. DNA was purified by phenol/chloroform/isoamyl alcohol extraction and polyethylene glycol precipitation.
The V4 variable region of the 16S rRNA gene was amplified by PCR with dual barcoded primers as described previously 27 . PCR amplicons were purified by AMPure XP magnetic purification beads (Beckman Coulter) and quantified using the Quant-iT PicoGreen ds DNA Assay Kit (Life Technologies Japan). The pooled amplicons were sequenced on a MiSeq (Illumina, 2 × 250 bp paired-end reads) according to the manufacturer's instructions. The 16S rRNA reads were processed with Mothur following the mothur MiSeq SOP (http://www.mothur.org/wiki/ MiSeq_SOP). In brief, the assembled reads were screened to eliminate reads containing ambiguous bases and then aligned to the SILVA 16S rRNA sequence database. UCHIME 28 was used to remove chimaeric sequences. The remaining reads were clustered into 97% identity operational taxonomic units (OTUs) and then assigned taxonomy using the RDP database (trainset9_032012.pds). OTUs of less than 0.01% relative abundance were eliminated and the resulting OTU table was rarefied to 15,000 reads per samples.
Histology and immunohistochemistry. Freshly isolated colons were snap-frozen embedded in optimum cutting temperature compound (Sakura) in a Swiss roll and stored at −80°C. Cryostat sections (6 µm) were fixed in acetone at −20°C for 5 min and stained with haematoxylin and eosin or with Alcian blue (Wako) and Nuclear Fast Red. For immunohistochemistry, rabbit anti-mouse IgA was purchased from Rockland Antibodies & Assays and Alexa Fluor 568 goat anti-rabbit IgG was purchased from Life Technologies. Concentration-matched isotype control antibodies were applied to each immunohistochemical staining to ensure the specificity of antibody.
W27 oral treatment of mice. For all oral treatments of W27 except for that reported in Fig. 3b , W27 (precipitated with ammonium sulfate) was administered in drinking water (tap water) to mice ad libitum. Drinking water with or without W27 was renewed once a week. In the experiment in Fig. 3b, 30 µg of affinity-purified W27 in PBS was administered to AID −/− mice with a gastric tube twice a week ad libitum.
Flow cytometry analysis for germinal centre B cells. Peyer's patches were excised from the small intestine. Single-cell suspensions were stained with the following antibodies (eBioscience): PE-Cy7-labelled anti-mouse/human CD45R (B220) (RA3-6B2), APC-labelled streptavidin. Biotinylated peanut agglutinin was obtained from Vector Laboratories. Dead cells were excluded by propidium iodide. The stained samples were analysed on a BD Accuri C6 (BD Bioscience) and with Kalusa software (Beckman Coulter).
Bacterial cell numbers analysis for W27 oral treatment. Bacterial genomic DNA was isolated as described previously 20 . In brief, faecal samples were suspended in extraction buffer (100 mM Tris-HCl, 40 mM EDTA (pH 9.0) and 10% SDS). Glass beads (diameter, 0.1 mm TOMY) and buffer-saturated phenol were then added to the faecal suspension. The suspensions were mixed vigorously on a FastPrep FP 120 instrument (BIO 101, Vista). After centrifugation, the supernatants were collected, and DNA was extracted with phenol/chloroform. Finally, DNA was reconstituted in TE-buffer. qPCR amplification and detection were performed in 384-well optical plates on an ABI PRISM 7900HT sequence detection system (Applied Biosystems) with group-specific primers for B. coccoides group, C. leptum subgroup, Atopobium cluster, Bacteroides fragilis group, Prevotella, Eubacterium cylinderroides, Lactobacillus and Enterobacteriaceae (Supplementary Table 3) 29-31 . DNA samples purified from the corresponding number of cells derived from each type-strain of eight bacterial groups were used as qPCR standard to obtain the numbers of each bacterial group.
We confirmed the uniqueness of amplification for the eight group-specific primer pairs by calculating the percentage of matched rRNA gene sequences in each genus from the RDP database (release 11, update 2; used for 16S rRNA genes) 32 and the SILVA Large Subunit Ref database (release 117; used for 23S rRNA genes) 33 within one mismatch with the RDP ProbeMatch (https://rdp.cme.msu.edu/ probematch/search.jsp) and SILVA TestPrime programs (http://www.arb-silva.de/ search/testprime/). The results are provided in Supplementary Table 3 .
DNA extraction for sequencing of 16S rRNA genes. Faeces samples were freezedried overnight. Freeze-dried faeces were broken with 3.0 mm zirconia beads in a Shake Master (Biomedical Science). Ten milligrams of faeces were suspended in 200 µl of 10% SDS/TE buffer. Bacterial cells in buffer were broken with 0.1 mm zirconia/silica beads (BioSpec Products) by vigorous shaking for 5 min at 1,500 r.p.m. The homogenates were centrifuged to isolate DNA for 10 min at 14,000 r.p.m. The extracted DNA was purified in phenol/chloroform/isoamyl alcohol (25:24:1) solution, precipitated by adding ethanol and 3 M sodium acetate, and stored at −20°C.
Sequencing of 16S rRNA genes. The effects of W27 oral treatment for mice gut microbiota were analysed by two experiments. First, comparison of the mean relative abundances of each family of microbiota before and after W27 oral treatment was conducted using a 454 GS JUNIOR sequencer-based 16S rRNA gene sequencing analysis. Second, comparison of 97% identity OTU abundances of microbiota between W27 and water oral treatment to wild-type and AID −/− mice in DSS-induced colitis was conducted using an Illumina MiSeq sequencer-based 16S rRNA genes amplicon paired-end sequencing analysis. In both experiments, 338F (5′-ACTCCTACGGGAGGCAGCAGT-3′) 34 and 806R (5′-GGACTACCAGGGTATCTAAT-3′) 35 primers were used to amplify the 16S rRNA genes of gut microbiota. The mixed samples were prepared by pooling approximately equal amounts of PCR amplicon from each sample and were then subjected to the 454 GS JUNIOR and Illumina MiSeq sequencer.
In the 454 GS JUNIOR sequencer-based analysis we obtained high-quality reads after removal of the reads that (1) contained ambiguous nucleotides, (2) contained <350 or >650 nt and (3) were associated with an average Phred-like quality score of less than 25 as calculated by the 454 GS JUNIOR sequencer. Both the forward and reverse primer sequences were removed by a TagCleaner (version 0.12) search with three allowed mismatches 36 . Sequence clustering of the high-quality 454 reads was conducted using UCLUST (version 6.0.307) with identity >97%, and query and reference coverage >80% (ref. 28) . Chimaeric OTUs were detected and removed if the OTUs were assigned to chimaera in both of the following methods: (1) a UCHIME (version 6.0.307) 28 reference mode search against the reference gold database (http://drive5.com/uchime/gold.fa) and (2) a UCHIME de novo mode search. Taxonomic assignment of the high-quality 454 reads was performed by a RDP MultiClassifier (version 1.1) search with bootstrap value >0. 5 (ref. 37) .
In the Illumina MiSeq sequencer-based analysis, we discarded reads that (1) contained ambiguous nucleotides and (2) were mapped to the PhiX genome sequence by a Bowtie 2 (version 2.1.0) search with default parameters 38 . Each forward and reverse read for the paired-end library was then merged by a USEARCH (version 6.0.307) with-fastq_truncqual 7 parameter. Both forward and reverse primer sequences were removed by a TagCleaner search with three allowed mismatches. We obtained high-quality reads after removal of the reads that (1) contained <350 or >650 nt and (2) were associated with an average Phred-like quality score of less than 25 as calculated by the Illumina MiSeq sequencer. The 97% identity OTU clustering and chimaera filtering were performed in the same way for the 454 GS JUNIOR sequencer-based 16S rRNA genes amplicon sequencing analysis. Compositional differences of the 97% identity OTUs among mice with different treatments were visualized by hierarchical clustering analysis with the Bray-Curtis dissimilarity index and statistically analysed by a permutational multivariate analysis of variance (PERMANOVA) in the vegan library of the R software.
DSS-induced colitis. DSS (MP Biomedicals, M w = 36,000-50,000), at designated concentrations in the drinking water, (hypochlorous acid water) was administered to mice ad libitum. The mice that died before the end of the experiments (two watertreated mice and one W27-treated mouse in Fig. 5a ) were excluded. Disease activity index was scored based on criteria 21 (Supplementary Statistics. Statistical analyses were performed by designated procedures as described in each figure legend. P < 0.05 was considered significant. Accession codes. The nucleotide sequences determined in this study were deposited in the DDBJ Sequence Read Archive under DDBJ BioProject ID no. PRJDB3207.
